BioHealth News Archive
PGDx becomes latest Baltimore biotech to raise mega-deal, with $103M Series C – Baltimore Business Journal
Luis Diaz, co-founder of PGDx, said the new funding will allow the company to "go out and sell" the cancer diagnostics tech it has…
Read More
Lessons learned from Johns Hopkins’ high-profile COVID-19 website | Healthcare Finance News
Here's a look at how Johns Hopkins' COVID-19 website was created and how it grew visits to more than 38 million in seven months.…
Read More
These 6 pandemic fatigue-fighting creative campaigns won University System of Maryland’s Public Health Challenge – Technical.ly Baltimore
University System of Maryland (USM) asked members of its community to get creative with approaches to educating the public on COVID-19 safety ahead of…
Read More
CarrTech raising funding to reach FDA finish line as Covid creates demand for needle filter system – Washington Business Journal
The Montgomery County startup is raising new funding — and eyeing an eventual sale of the business. Image: Sue Carr designed an alternative to…
Read More
NexImmune Announces Pricing of Upsized Initial Public Offering
GAITHERSBURG, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc., a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the…
Read More
Johns Hopkins again tops research and development spending list as University of Maryland jumps over 30 spots – Baltimore Business Journal
Maryland is now one of only six states with more than one university entity spending $1 billion or more per year on research, according…
Read More
Winners Selected for University System of Maryland Public Health Challenge – USM
Baltimore, Md. (Feb. 11, 2020) – The University System of Maryland (USM) COVID Research & Innovation Task Force today announced the six winning teams…
Read More
WHO approves AstraZeneca/Oxford COVID-19 vaccine for emergency use | Reuters
GENEVA (Reuters) - The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the…
Read More
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
GAITHERSBURG, Md., Feb. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK…
Read More
AI Can Increase Efficiency in Healthcare, Even in a Pandemic | HealthTech Magazine
Artificial intelligence is often depicted in popular movies and TV dramas as technology that is determined to take over the world. Just a few…
Read MoreEnormous ancient fish discovered by accident | EurekAlert! Science News
Fossilised remains of a fish that grew as big as a great white shark and the largest of its type ever found have been…
Read More
How American universities can promote innovation: My long-read Q&A with Korok Ray | American Enterprise Institute – AEI
A key component of America’s ability to innovate is its world-renowned system of higher education, which is the envy of the world. owever, there’s room…
Read More
For mRNA vaccines, COVID-19 is just the beginning | Hub
Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases Even the experts were…
Read MoreRockville’s Sensei Biotherapeutics’ IPO hits $133M – Washington Business Journal
It's the latest in a series of public offerings for Greater Washington life sciences companies. Image: John Celebi is CEO of Sensei Biotherapeutics RICHARD…
Read More
BioHealth Innovation Adds Four NIH New Entrepreneurs-in-Residence
Renée JG Arnold, John Reinhart, Don Rose, and Kwame Ulmer join Diverse Entrepreneurs-in-Residence (EIR) Team ROCKVILLE, MARYLAND, February 8, 2021 – BioHealth Innovation…
Read More